NuCana Plc (NCNA)
1.09
-0.08
(-6.84%)
USD |
NASDAQ |
Oct 02, 16:00
1.00
-0.09
(-8.26%)
After-Hours: 20:00
NuCana EPS Diluted (Quarterly) : -1.007 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.007 |
| March 31, 2026 | -1.28 |
| December 31, 2025 | -0.7979 |
| September 30, 2025 | -0.1349 |
| June 30, 2025 | -31.11 |
| March 31, 2025 | -102.57 |
| December 31, 2024 | -29.54 |
| September 30, 2024 | -2.427 |
| June 30, 2024 | -3.894 |
| March 31, 2024 | -4.046 |
| December 31, 2023 | -4.534 |
| September 30, 2023 | -4.022 |
| June 30, 2023 | -3.234 |
| March 31, 2023 | -4.562 |
| December 31, 2022 | -8.607 |
| September 30, 2022 | -2.574 |
| June 30, 2022 | -2.361 |
| Date | Value |
|---|---|
| March 31, 2022 | -5.451 |
| December 31, 2021 | -8.896 |
| September 30, 2021 | -5.361 |
| June 30, 2021 | -6.150 |
| March 31, 2021 | -6.578 |
| December 31, 2020 | -7.992 |
| September 30, 2020 | -7.723 |
| June 30, 2020 | -5.758 |
| March 31, 2020 | -3.961 |
| December 31, 2019 | -7.753 |
| September 30, 2019 | -3.748 |
| June 30, 2019 | -4.525 |
| March 31, 2019 | -5.498 |
| December 31, 2018 | -3.662 |
| September 30, 2018 | -2.606 |
| June 30, 2018 | -1.360 |
| March 31, 2018 | -6.958 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0437 |
| BioNTech SE | -3.799 |
| Silence Therapeutics Plc | -0.0866 |
| Compass Pathways Plc | -1.883 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.134M |
| Total Expenses (Quarterly) | 4.134M |
| Enterprise Value | -20.30M |
| Earnings Yield | -295.4% |
| Normalized Earnings Yield | -287.66 |